Jinyang Li
Principal Scientist Innovent Biologics
2022–Present, Innovent Biologics Guoqing Academy, Immunology Principal Scientist
2020–2021, The Rockefeller University, Postdoctoral Fellow
2014–2020, University of Pennsylvania, Ph.D.
2013, University of Cambridge, Visiting Scholar
2010–2014, Tsinghua University, B.S. in Life Sciences
Lead innovative biologics discovery for oncology and autoimmune diseases (mAbs, bispecific antibodies, fusion proteins, oligonucleotide therapeutics). 10 patent applications, 30+ peer-reviewed publications (10 as first author), 3,500+ citations
Seminars
Wednesday 25th March 2026
Development & Characterization of IBI3055, a 2+1 Format, CD19 & BCMA Dual Targeting T-Cell Engager for Autoimmune Diseases
1:30 pm
- Novel T-cell engager for autoimmune diseases
- CD19 and BCMA targeting therapies for B-cell and plasma cell depletion
- New therapeutic approaches for drug for immune resetting
